Molecular Mechanisms of Resistance to KRAS G12C Inhibitors in NSCLC- From Genomic Evolution to TME Adaptation
targeted therapies and discuss evolving therapeutic strategies designed to overcome adaptive resistance in KRAS mutant malignancies.
Authors
- Mercy Jacquiline
- Simmy Mehta
- Neeru Singh
- Yugshree Vidhyarthi
Publication Details
- Journal
- Journal of drug targeting
- Published
- 2026-09-28
- DOI
- https://doi.org/10.1080/1061186x.2026.2741202
- Primary Topic
- Protein Kinase Regulation and GTPase Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00